Actively Recruiting

Phase 4
Age: 20Years +
All Genders
NCT06834230

Effect of Dotinurad in Hyperuricemia With Hypertension

Led by Saga University · Updated on 2025-12-15

360

Participants Needed

1

Research Sites

261 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The effect of dotinurad on CAVI (cardio-ankle vascular index) will be compared with that of febuxostat in patients with hyperuricemia complicated by hypertension.

CONDITIONS

Official Title

Effect of Dotinurad in Hyperuricemia With Hypertension

Who Can Participate

Age: 20Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 20 years or older at the time of consent (all genders)
  • Hyperuricemia with serum uric acid level greater than 7.0 mg/dL
  • No urate lowering drug use within 27 days prior to consent, or off such drugs for more than 27 days if previously treated
  • Hypertensive patients meeting the latest Japanese Society of Hypertension definition
  • Stable hypertension treatment without changes in the 4 weeks before eligibility
  • Provided written consent to participate in the study
Not Eligible

You will not qualify if you...

  • Unsettled gout after acute gouty arthritis
  • Current urinary tract stones
  • Known secondary hyperuricemia due to specific syndromes or diseases including Lesch-Nyhan syndrome, hematopoietic tumors, solid tumors, and others listed
  • Hypertensive emergencies or urgency
  • Active malignancies
  • Severe liver dysfunction
  • Severe kidney dysfunction with oliguria or anuria
  • Pregnant, possibly pregnant, or lactating
  • History of hypersensitivity to dotinurad or febuxostat
  • Receiving mercaptopurine hydrate or azathioprine
  • Any other condition deemed inappropriate by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Saga University

Saga, Saga-ken, Japan, 840-8502

Actively Recruiting

Loading map...

Research Team

K

Koichi Koichi, Pr.,Dr.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Effect of Dotinurad in Hyperuricemia With Hypertension | DecenTrialz